SENNA TABS- senna tablet, film coated 
ATLANTIC BIOLOGICALS CORP.

----------

Drug Facts

Active ingredient (in each tablet)

Sennosides 8.6mg

Purpose

Laxative

Uses

Warnings

Do not use

for more than one week unless directed by a doctor

Ask a doctor before use if you

  • have abdominal pain, nausea, or vomiting
  • are taking mineral oil
  • noticed a sudden change in bowel habits that last over 2 weeks

Stop use and ask a doctor if

  • you have no bowel movement within 12 hours
  • you have rectal bleeding

These could be signs of a serious condition

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase if needed, or as directed by a doctor
4 tablets twice a day, in the morning and at bedtime
children under 12 years
ask a doctor
ask a doctor

Other information

INACTIVE INGREDIENTS:

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil

Questions?

Adverse drug event call: (866) 562-2756

DISTRIBUTED BY:

ATLANTIC BIOLOGICALS CORP.

MIAMI, FL 33179

image description

SENNA TABS 
senna tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:17856-0363(NDC:16103-363)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN) SENNOSIDES A AND B8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
MINERAL OIL (UNII: T5L8T28FGP)  
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize10mm
FlavorImprint Code S8
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:17856-0363-1100 in 1 BOX, UNIT-DOSE05/09/2024
1NDC:17856-0363-31 in 1 POUCH; Type 0: Not a Combination Product
2NDC:17856-0363-2100 in 1 BOX, UNIT-DOSE05/09/2024
2NDC:17856-0363-41 in 1 POUCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01/24/2007
Labeler - ATLANTIC BIOLOGICALS CORP. (047437707)
Establishment
NameAddressID/FEIBusiness Operations
UNIT DOSE SOLUTIONS360804194repack(17856-0363)

Revised: 5/2024
Document Id: c1e27c0b-f9bb-4047-a0ea-6585bde60784
Set id: cd6e3fb4-0c5a-4aa7-89ea-109c6d072efe
Version: 3
Effective Time: 20240509
 
ATLANTIC BIOLOGICALS CORP.